Global Reach MDI Membrane Technologies has over 35 years of membrane production experience and active sales in more than 50 countries, indicating potential for expanding into additional biopharmaceutical and rapid diagnostics markets and leveraging existing international channels.

Quality and Compliance With ISO 9001:2008 certification, select ISO 13485 certified medical products, a Drug Master File with US FDA, and rigorous toxicity and biosafety standards, there is a strong selling point for GMP-aligned collaborations and contract manufacturing arrangements with pharma and biotech firms seeking compliant membrane solutions.

Customization Advantage MDI emphasizes customizable, validated dead-end filtration products that deliver cost savings, offering a competitive edge for target accounts facing unique filtration challenges or scale-up needs in biopharma and rapid diagnostics.

Mid-Sized Opportunity With a revenue range of one to ten million and a lean headcount, MDI sits between niche specialty suppliers and large incumbents, presenting opportunities to win medium-sized, recurring filtration contracts and strategic technology partnerships.

Strategic Collaborations The combination of a drugs filing with FDA, extensive product range, and a scalable GMP facility positions MDI as a potential partner for joint development, regulatory filings, and co-branded filtration solutions with larger biopharma players aiming to diversify their filtration portfolios.